1. Department of Medicine V, LMU University Hospital, LMU Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany;
2. Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
3. National Heart and Lung Institute, Imperial College, London, United Kingdom;
4. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York;
5. Department of Pathology and
6. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, and
7. Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts;
8. Firestone Institute for Respiratory Health, St. Joseph’s Healthcare and McMaster University, Hamilton, Ontario, Canada;
9. Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada;
10. Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, ERN-LUNG, Louis Pradel Hospital, Hospices Civils de Lyon, UMR 754, INRAE, Claude Bernard University Lyon 1, Lyon, France;
11. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York;
12. Royal Prince Alfred Hospital and
13. University of Sydney, Sydney, New South Wales, Australia;
14. St. Vincent’s Hospital, Sydney, New South Wales, Australia;
15. Section of Pulmonary and Critical Care, Department of Medicine, and
16. Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois;
17. Women’s Guild Lung Institute, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California;
18. Unit for Interstitial Lung Diseases, Department of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium;
19. Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia;
20. Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan;
21. Università Cattolica del Sacro Cuore, Rome, Italy;
22. Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy;
23. Center for Interstitial Lung Diseases, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, and
24. Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington; and
25. Royal Brompton Hospital and Imperial College, London, United Kingdom